Gonorrhoea : Study
The U.S. Food and Drug Administration (FDA) recently granted approval for two new oral medicines, Nuzolvence (zoliflodacin) and Blujepa (gepotidacin), to treat gonorrhoea, a common sexually transmitted infection, prone to resistance against drugs.
- It is a preventable and curable sexually transmitted infection (STI) caused by the bacteria Neisseria gonorrhea.
- It’s also sometimes called “the clap” or “drip.”
- Gonorrhea bacteria can infect the urethra, rectum, female reproductive tract.
- It is most commonly spread during vaginal, oral or anal sexual activity.
- Gonorrhea can affect people of any age, anatomy, or gender, but it’s particularly common among teens and young adults between the ages of 15 and 24
- It can cause a sore throat, conjunctivitis, unusual vaginal or penile discharge, and pelvic and genital pain.
- Untreated gonorrhoea can cause:
- infections affecting the skin, joints, heart (endocarditis), and brain (meningitis)
- infertility in both females and males
- pelvic inflammatory disease (PID)
- epididymitis and prostatitis
- Some of these complications can cause permanent damage to health.
- Treatment: Gonorrhoea is treatable and curable with antibiotics.
